About HKTDC | Media Room | Contact HKTDC | Wish List Wish List () | My HKTDC |
繁體 简体
Save As PDF Print this page
Qzone

Upgraded Requirements Introduced for Dietary Supplement Labelling

New labelling requirements with regard to dietary supplements were introduced by the China Food and Drug Administration (CFDA) on 14 February this year and came into immediate effect.

Overall, four new requirements have been introduced:

  • In the case of dietary supplements that have not been previously trialed for human use, the words “This product has been tested on animals” must be prefixed to any claims regarding efficacy on the product’s label and on any accompanying literature
  • All manufacturers of dietary supplements are obliged to change their labelling and literature in line with the above stipulation before the end of 2020
  • Any failure to amend all such labelling and literature in the specified manner will be subject to investigation and prosecution in accordance with the relevant provisions of the Food Safety Law of the People’s Republic of China with effect from 1 January 2021 onwards
  • In the case of dietary supplements that have been previously tested on human subjects, specific details of the evaluation process and labelling requirements will be stipulated separately

For further details (in Chinese), please visit the following link:

Announcement of CFDA on Standardising the Label Claims of Dietary Supplements (No. 23 [2018])

 

Content provided by Picture: HKTDC Research
Comments (0)
Shows local time in Hong Kong (GMT+8 hours)

HKTDC welcomes your views. Please stay on topic and be respectful of other readers.
Review our Comment Policy

*Add a comment (up to 5,000 characters)